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A B S T R A C T
Coronavirus Disease-2019 (COVID-19) originated in the Wuhan, Hubei Province, China in November 2019 and
has since been declared a pandemic by the WHO. COVID-19 is an acute infectious disease, primarily affecting the
respiratory system. Currently, real-time reverse transcription polymerase chain reaction (RT-PCR) performed on
respiratory specimens is considered the reference by which to diagnose COVID-19. However, the limitations of
RT-PCR, specifically, the fact that it is time-consuming and inadequate for the assessment of disease severity,
have affected the process of epidemiological disease containment and has taken a toll on the healthcare man-
agement chain. As the risk of infection for other patients and personnel must be kept to a minimum, the in-
dications for imaging have to be carefully considered. Imaging is primarily performed in patients with a negative
RT-PCR, but a high clinical suspicion of COVID-19, or, in patients with diagnosed COVID-19 who are suffering
from moderate to severe symptoms. In this article, we review the typical imaging findings in COVID-19, the
differential diagnoses, and common complications.
1. Background
In late November 2019, a serious form of pulmonary illness origi-
nated in Wuhan City (Hubei Province, China) and engulfed a majority
of the world [1]. This pneumonia outbreak was attributed to a novel
coronavirus, a lipid-enveloped RNA virus, which was named by the
International Committee on Taxonomy of Viruses severe acute re-
spiratory syndrome coronavirus 2 (SARS-CoV2) [2]. The disease caused
by the virus was termed coronavirus disease-2019 (COVID-19). The
virus outbreak presumably originated via a zoonotic transmission
linked to the seafood market in Wuhan (China) and later accelerated
with human to human transmission, causing the severe subsequent
outbreak [1]. Since the original outbreak, SARS-CoV2 has rapidly
spread across the world and, in January 2020, the World Health Or-
ganization (WHO) declared COVID-19 a global public health emergency
[3]. By the 21 st of April 2020, more than 2.4 million individuals tested
positive for SARS-CoV2, and it had caused more than 165,000 deaths
[4].
In order to enter the human host cells, SARS-CoV2 attaches to an-
giotensin-converting enzyme 2 (ACE2) on the surface of the cells via its
viron spike protein [5]. ACE2 is highly expressed on the surface of
pulmonary epithelial cells, which explains the frequent pulmonary in-
volvement in COVID-19 [5]. In addition to pulmonary epithelial cells,
ACE2 is also expressed in the heart, ileum, kidney, bladder, and en-
dothelial cells [5]. The involvement of endothelial cells might be the
reason for the hypercoagulable state observed in some patients with
severe disease [5].
COVID-19 includes a wide spectrum of symptoms, ranging from
upper respiratory infection to perilous pneumonia, allied with acute
respiratory distress syndrome (ARDS). The most common symptoms at
presentation are fever, fatigue, dry cough, myalgia, and dyspnea [6].
Less commonly, patients present with headache, hemoptysis, diarrhea,
or pleuritic chest pain [6].
Currently, real-time reverse transcriptase polymerase chain reaction
(RT-PCR) on upper and lower respiratory track specimens is considered
the reference standard with which to diagnose COVID-19 [7]. The
sensitivity of the RT-PCR for diagnosing COVID-19 ranges between 50
% and 98 %, depending on the sampling of the specimen, the stage of
the infection, and the quality of the test [8], with a pooled sensitivity
estimate of 89 % [9]. Therefore, RT-PCR in symptomatic patients may
initially yield negative results that may turn positive on repeat testing
[10].
2. Role of imaging in the diagnosis of COVID-19 pneumonia
Imaging indications for the diagnosis and follow-up of patients with
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COVID-19 have been addressed by a number of scientific societies
[11–13]. There is a general consensus that the imaging indications
should be applied uniformly and carefully weighted to minimize the
risk of infection to medical personnel and other patients.
Chest radiography is the most readily available modality for the
detection of lung abnormalities in many centers. Compared to chest
computed tomography (CT), chest radiographs are cheaper and are
associated with a lower radiation dose. However, the lack of specificity,
as well as sensitivity for detection of COVID-19, particularly in patients
with no or only minor symptoms, must be considered [11,14]. For ex-
ample, in suspected COVID-19 patients who eventually tested positive
on RT-PCR, the reported sensitivity of baseline chest radiographs was
reported to be 69 % [2]. Consequently, chest radiographs should be
performed primarily in patients with moderate to severe symptoms to
assess disease progression or diagnose complications [11]. The routine
use of chest radiographs, however, is not considered to be indicated in
stable, intubated patients with COVID-19 [11].
The American College of Radiology supports the view that the need
for CT decontamination required after scanning a COVID-19 patient
may interrupt radiological service accessibility, and proposes that
portable chest radiographs should be considered to decrease the risk of
cross-infection [13].
Chest ultrasound is primarily performed in some centers to triage
patients, to monitor treatment effects, and for diagnosing complications
of COVID-19 pneumonias, such as pleural effusions [15,16]. As with all
other bed-side procedures in COVID-19 patients, ultrasound examina-
tions should be kept to a minimum to avoid the risk of infection of the
medical personnel.
Chest CT offers the advantage of providing significant information.
The indication for CT depends primarily on the clinical context and
resource constraints [11]. In general, imaging is not recommended for
screening in asymptomatic individuals or in patients with RT-PCR
confirmed COVID-19 and only mild clinical symptoms [11,12].
CT is recommended in COVID-19 patients with moderate to severe
symptoms at baseline and in case of progressing clinical symptoms
[11]. Furthermore, CT has a role in estimation of disease severity of
COVID-19 and to steer clinical management. For example, CT can
provide an estimate of the proportion of unaffected, normally aerated
lung, which has been linked to improved outcome [17]. A thorough
analysis should be done regarding the potential benefit of the ex-
amination against the financial costs and exposure to ionizing radiation.
Using modern CT scanners, however, the radiation dose, motion arti-
facts, as well as beam-hardening artifacts, can be reduced significantly
[18].
Considering the variable sensitivity of RT-PCR, imaging may be of
value in patients with a negative RT-PCR, but a high clinical suspicion
of COVID-19 with moderate to severe symptoms. In such cases, ima-
ging, particularly CT, may aid in differentiating between COVID-19 and
alternative diagnoses. If imaging findings are suggestive of COVID-19,
serial RT-PCR should be performed to confirm the diagnosis [11].
It is noteworthy that a negative chest CT does not exclude COVID-
19, particularly if CT is performed in the first few days after the onset of
symptoms [19–21].
In patients with RT-PCR-confirmed COVID-19 and moderate or se-
vere symptoms, imaging can be used for risk stratification and to es-
tablish a baseline pulmonary status [11].
In COVID-19 patients with progressing clinical symptoms, imaging
is helpful to diagnose or to rule out complications, such as bacterial
superinfections, pulmonary embolism, or heart failure [11].
Given the low availability of PET/CT, its costs, the high radiation
dose, and limited clinical consequences, the routine use of this modality
in COVID-19 is not indicated. A retrospective case series of four patients
who were investigated with 18F-FDG PET/CT in COVID-19 reported a
high 18F-FDG uptake in areas of ground glass and consolidation [22].
3. Chest radiograph findings in COVID-19
The most common findings on chest radiographs are multifocal
ground-glass opacities and consolidation with a peripheral and lower
lung zone predilection. Lung involvement may or may not be bilateral
[23,24] (Fig. 1).
4. Chest ultrasound findings in COVID-19
As COVID-19 pneumonia has a predilection for the lung periphery,
it can principally be assessed by transthoracic ultrasound. Transthoracic
ultrasound may detect subpleural consolidations and variations of air
and water content in lung tissue. It may show thickened irregular
pleura and vertical reverberation artifacts that originate from the
pleura (so-called “B-lines”) in a variety of patterns, including focal,
multifocal, and confluent. In addition, it may show focal or multifocal
consolidations, occasionally with mobile air bronchograms [25].
Pleural effusions are uncommon in COVID-19.
5. Chest CT findings in COVID-19
Although CT findings of COVID-19 are nonspecific, in the appro-
priate clinical setting with a high disease prevalence, CT findings in
COVID-19 are highly suggestive of COVID-19. However, they do require
RT-PCR confirmation.
The most common initial CT findings in COVID-19 pneumonia are
multifocal, patchy, or rounded ground-glass opacities that most fre-
quently occur bilaterally and in the lung periphery with a basal pre-
dominance (Fig. 2 and 3). Ground-glass opacities are observed in 88 %
of the patients [26]. Those initial changes most likely correspond to
pulmonary edema with hyaline membrane formation, indicating an
early stage of diffuse alveolar damage [27].
Consolidations are present in about one-third of the cases on the
initial CT and occur with increasing frequency as the disease progresses
(Fig. 4) [26]. In some patients, the consolidations are linear (referred to
as “fibrous stripes” by some authors), most probably reflecting orga-
nizing pneumonia as a response to lung injury (Fig. 5) [28,29]. In some
Fig. 1. An 84-year-old female patient with dyspnea for two weeks, no fever, no
cough. The chest radiograph shows ill-defined consolidations in the periphery
of the mid- and lower-lung fields of both lungs. COVID-19 was confirmed by
RT-PCR.
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patients, the intra- and perilesional pulmonary vessels are engorged,
indicating an increased perfusion of these areas [29,30].
In addition to ground-glass opacities and consolidations, ground-
glass superimposed with reticular abnormalities—termed crazy pa-
ving—and areas of ground-glass surrounded by a ring of con-
solidation—termed the reversed halo sign—have also been observed
[31–34].
In most cases, lesions are multifocal (70 %) and located in the lung
periphery. Occasionally, they occur centrally in a bronchovascular
distribution (12 %) or a combination of both (44 %–59 %) [20,35,36].
Typically, the lesions are found in both lungs with a slight pre-
dominance for the lower lobes [31–34,36].
In severe cases, CT shows diffuse heterogeneous consolidation with
ground-glass opacities, air bronchograms, and bronchiectasis, pre-
senting as “white lung” when most lung lobes are affected [37]. The
presence of multiple bilateral lobular and subsegmental consolidations
on CT were associated with an increased frequency of intensive care
unit admission [38]. Patients also may occasionally present with
thickening of interlobar septa and the bilateral pleura [39].
Pleural effusion, lung cavitation, lymphadenopathy, and calcifica-
tion are not typically seen [30,40]. Centrilobular nodules with the tree-
in-bud pattern are not distinctive and likely indicate other causes of
pneumonia.
Over the course of the disease, GGOs were observed to be rapidly
growing, demonstrating consolidation and a crazy-paving pattern as the
disease progresses. The peak of CT morphological lung involvement
occurs between day 9 and 13 after the initial onset of symptoms, fol-
lowed by slow gradual clearing [41].
6. Differential diagnoses of COVID-19 pneumonia
Although the CT findings in COVID-19 pneumonia are character-
istic, they lack specificity and require confirmation by RT-PCT. The
Fig. 2. A 27-year-old female patient with chest pain and chough. CT shows
patchy areas of ground-glass in the periphery of both lower lobes. RT-PCR
confirmed the suspicion of COVID-19.
Fig. 3. A 47-year-old male patient with COVID-19 with fever and dry chough.
CT shows rounded areas of ground-glass opacities in the periphery of both
lungs.
Fig. 4. A 60-year-old patient with deteriorating pulmonary function ten days
after hospital admission and acute respiratory distress syndrome (ARDS). The
CT scan depicts consolidations in the dorsal aspects of the lower lobes, fre-
quently encountered in ARDS. Heterogeneous ground-glass opacifications in the
nondependent lung are found in the subpleural peripheral lungs—a char-
acteristic finding in COVID-19 cases. A combination of smooth, interlobular,
septal thickening in areas of ground-glass attenuation, also described as the
crazy-paving pattern, were also present and have been described in COVID-19
(encircled).
Fig. 5. A 50-year-old male patient with a fever of up to 38 °C, cough, and
dyspnea and negative RT-PCR. CT performed on the same day shows an orga-
nizing pneumonia type of appearance with peripheral arcades and linear opa-
cities in both lungs, with a lower lobe and peripheral predominance. Repeated
RT-PCR one day later confirmed SARS-CoV2 infection.
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most important differential diagnoses are other pulmonary infections,
heart failure (Fig. 6), eosinophilic pneumonia, and organizing pneu-
monias of other etiologies.
Influenza virus pneumonias show unilateral or bilateral ground-
glass opacities with multifocal areas of consolidation, which are pre-
dominantly peri-bronchovascular and subpleural in distribution [42].
RSV (Respiratory syncytial virus) infection exhibits multiple, cen-
trilobular nodules with bronchial wall thickening (Fig. 7) [42]. Ade-
novirus infection shows multifocal consolidation with random ground-
glass opacities and a predilection for lobar collapse that involves the
right upper lobe (common in children) [42]. Severe acute respiratory
syndrome coronavirus (SARS- 2003) and Middle East respiratory syn-
drome coronavirus (MERS-2012) manifests with peripheral, bilateral,
focal or multifocal ground-glass opacities and consolidations [43].
Mycoplasma pneumonia frequently shows areas of ground-glass
attenuation, patchy consolidations in a lobular distribution, and ill-
defined centrilobular nodules with thickening of the bronchovascular
bundles [44].
7. Complications in COVID-19
7.1. Bacterial superinfections
The presence of pleural effusions, multiple lung nodules, and lym-
phadenopathy on imaging may point toward a co-existing bacterial
superinfection. Furthermore, tree-in-bud opacities or cavities are not
typical and also point toward a superinfection [14].
7.2. Acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS) describes the most se-
vere complication of pulmonary impairment in the form of diffuse al-
veolar damage caused by SARS-CoV2. Clinically, patients present with
significant arterial de-oxygenation and respiratory failure. Lung ima-
ging, particularly CT, shows bilateral diffuse areas of ground-glass
opacities with or without admixed consolidations (Fig. 8) [45].
7.3. Cardiac involvement
Cardiac involvement as a complication of SARS-CoV-2 infection is
rare [46]. Myocarditis due to viral insult ensues after focal or global
myocardial inflammation and eventually leads to ventricular dysfunc-
tion [47]. The electrocardiography, laboratory tests, and wall-motion
abnormalities found on echocardiographs in COVID-19 patients may
resemble coronary heart disease and should prompt further evaluation
using cardiac MRI, once obstructive coronary artery disease is excluded
[46]. Cardiac MRI findings reveal diffuse edema and the slow gadoli-
nium washout favors a diagnosis of acute myocarditis [47].
Fig. 6. A 59-year-old male patient with acute dyspnea and suspected COVID-19
pneumonia. CT shows minor, bilateral, pleural effusions, diffuse ground-glass
opacities, and broncho-centric consolidations that spared the lung periphery.
The CT findings were suspected to be more compatible with heart failure, which
was confirmed clinically with multiple RT-PCR that was negative for SARS-
CoV2.
Fig. 7. A 55-year-old male patient with progressive dyspnea after hemato-
poietic stem cell transplantation. CT shows multiple, centrilobular, nodular
ground-glass opacities compatible with a respiratory syncytial virus (RSV)
pneumonia, which was confirmed by PCR.
Fig. 8. A 50-year-old female patient with RT-PCR-confirmed COVID-19 pneu-
monia complicated by acute respiratory distress syndrome (ARDS). The chest
radiograph shows confluent ill-defined consolidations in both lungs, with a
predominance in the lower lung fields. The patient was intubated and on extra-
corporeal membrane oxygenation (ECMO).
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7.4. Pulmonary embolism
Pulmonary embolism appears to be a frequent complication in pa-
tients with COVID-19 pneumonia (Fig. 9). In a retrospective study that
investigated 106 COVID-19 patients, a pulmonary embolism was de-
tected in 30 % of the cases, which is much higher than the 1.3 % de-
tection rate of pulmonary embolism detected in critically ill patients
[48].
7.5. CNS involvement
Acute necrotizing encephalopathy (ANE) has been previously re-
ported as a rare complication of influenza and other viral infections. It
is thought to be related to the intracranial cytokine storm that causes
damage to the blood-brain barrier rather than a direct viral insult or
para-infectious demyelination [49].
On imaging, ANE most characteristically shows symmetric, multi-
focal lesions with invariable thalamic involvement. On CT, these lesions
are hypoattenuating, while MRI demonstrates a T2 FLAIR hyperintense
signal with internal hemorrhage [49]. On postcontrast images, a ring of
contrast enhancement may be visible [49].
8. Assessment schemes for COVID-19 pneumonia
To harmonize the reporting of CT findings and to give clinicians a
categorical estimate of the probability of a COVID-19 pneumonia,
several groups have developed assessment schemes for COVID-19
pneumonia [50–52]. In short, findings are categorized into typical
findings of COVID-19, indeterminate findings, atypical findings (Covid-
19 pneumonia unlikely, alternative diagnoses more likely) and normal
[50–52]. In addition to categorization, imaging findings should also be
roughly quantified into mild, moderate, and severe in order to allow a
risk estimation [14,50–52].
9. Conclusion
Imaging plays an important role in the management of COVID-19
patients. To minimize the risk of infection of other patients and medical
personnel, indications for imaging should be carefully weighed and
tailored to the clinical situation and resources available. Typical CT
features of COVID-19 pneumonia include multifocal bilateral GGOs,
with or without patchy consolidations, prominent peripheral subpleural
distribution, and posterior or lower lobe predilection. Thin-slice chest
CT help to achieve a prompt diagnosis, guide clinical decision-making,
and monitor disease progression, thus playing a critical role in the early
prevention and control of COVID-19.
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